<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94195">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02047955</url>
  </required_header>
  <id_info>
    <org_study_id>13B-T-SHOULDER-RM</org_study_id>
    <nct_id>NCT02047955</nct_id>
  </id_info>
  <brief_title>Tornier Shoulder Outcomes Study to Examine Safety and Functional Outcomes in Shoulder Arthroplasty and Fracture Patients</brief_title>
  <official_title>Tornier Shoulder Outcomes Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tornier</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tornier</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Tornier Shoulder Outcomes Study is designed to collect safety and efficacy data on
      designated commercially available Tornier Shoulder repair products.  In addition, this study
      will provide performance data for use in education, marketing materials, peer-reviewed
      publications and support research and development of future products.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <primary_completion_date type="Anticipated">January 2054</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Number of device associated and procedure associated adverse events</measure>
    <time_frame>up to 20 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of reoperation and revision surgery</measure>
    <time_frame>up to 20 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to first revision surgery</measure>
    <time_frame>up to 20 years</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline and previous visit in ASES scores</measure>
    <time_frame>at 1, 2, 5, 7, 10, 15, and 20 years of follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>ASES Score = American Shoulder and Elbow Surgeons Score</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline and previous visit in Adjusted and unadjusted Constant Murley Scores</measure>
    <time_frame>at 1, 2, 5, 7, 10, 15, and 20 years follow-up</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline and previous visit in SANE scores</measure>
    <time_frame>at 1, 2, 5, 7, 10, 15, and 20 years follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>SANE = Single Assessment Numeric Evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Change from baseline and previous visit in Subject Satisfaction</measure>
    <time_frame>at 1, 2, 5, 7, 10, 15, and 20 years follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed as improved, worsened or no change</description>
  </other_outcome>
  <other_outcome>
    <measure>Cumulative incidence of migration, radiolucency, osteolysis, and bone wear</measure>
    <time_frame>at 1, 2, 5, 7, 10, 15, and 20 years follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>as assessed by available X-ray, CT, or MRI</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Shoulder Arthroplasty and Fracture Repair</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from United States, European, Canada, and Australia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Willing and able to comply with the requirements of the study protocol

          -  Considered for treatment with one or more Tornier shoulder arthroplasty or fracture
             devices included in this study

        Exclusion Criteria:

          -  Patients who are not able to comply with the study procedures based on the judgment
             of the assessor will be excluded (e.g. cannot comprehend study questions, inability
             to keep scheduled assessment times)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas B Edwards, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Orthopaedic Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Armodios Hatzidakis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Othopaedics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexandre Laedermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital de la Tour</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lionel Neyton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Prive Jean Mermoz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steve Erickson</last_name>
    <role>Study Director</role>
    <affiliation>Tornier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondren Orthopedic Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas B Edwards, MD</last_name>
      <phone>713-799-2300</phone>
    </contact>
    <investigator>
      <last_name>Thomas B Edwards, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 19, 2014</lastchanged_date>
  <firstreceived_date>January 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
